<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is a B-lymphotropic human herpesvirus that infects the vast majority of the world's population; it establishes lifelong latency in the infected host </plain></SENT>
<SENT sid="1" pm="."><plain>The virus enters through the oropharyngeal mucus and replicates in epithelial cells </plain></SENT>
<SENT sid="2" pm="."><plain>The infiltrating B lymphocytes become infected and <z:mpath ids='MPATH_458'>normal</z:mpath> resting B cells activated by the virus result in immortalised B cell populations </plain></SENT>
<SENT sid="3" pm="."><plain>This growth program utilises <z:hpo ids='HP_0000001'>all</z:hpo> of the latent genes and proteins </plain></SENT>
<SENT sid="4" pm="."><plain>Following <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e>, the virus is found in saliva for weeks and <z:hpo ids='HP_0011010'>chronic</z:hpo> shedding participates in transmitting the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> from person to person through intimate kissing contact </plain></SENT>
<SENT sid="5" pm="."><plain>EBV causes <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, leads to EBV-induced malignant B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in immunosuppressed patients, and is implicated in the pathogenesis of several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the immunocompetent </plain></SENT>
<SENT sid="6" pm="."><plain>Laboratory confirmation of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> employing serological testing is generally required </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and reactivation however need additional investigations such as nucleic acids testing </plain></SENT>
<SENT sid="8" pm="."><plain>Quantitative polymerase chain reaction is now used as the major marker in B-cell proliferations either for assessing risk factors or for evaluating the efficacy of anti-EBV treatments </plain></SENT>
</text></document>